Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication

Frontiers in Physiology

Volumn 5 AUG, Issue , 2014, Pages

  Leucker, Thorsten M ^a   Jones, Steven P ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cardiomyocyte; Cardiovascular disease; Endothelial function; Juxtacrine communication; Paracrine factors

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 4; INDUCIBLE NITRIC OXIDE SYNTHASE; NEU DIFFERENTIATION FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTICLE; ATHEROSCLEROSIS; AUTOCRINE EFFECT; BIOAVAILABILITY; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL INTERACTION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 84906501274     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00328     Document Type: Article

References (92)

1. Andrew, P.J., and Mayer, B. (1999). Enzymatic function of nitric oxide synthases. Cardiovascular Research 43, 521- 531.
2. Baltogiannis, G.G., Tsalikakis, D.G., Mitsi, A.C., Hatzistergos, K.E., Elaiopoulos, D., Fotiadis, D.I., Kyriakides, Z.S., and Kolettis, T.M. (2005). Endothelin receptor-a blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc Res 67, 647-654.
3. Behrendt, D., and Ganz, P. (2002). Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90, 40L-48L.
4. Ben Driss, A., Devaux, C, Henrion, D., Duriez, M., Thuillez, C, Levy, B.I., and Michel, J.B. (2000). Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 101, 2764-2770.
5. Benjamin, E.J., Larson, M.G., Keyes, M.J., Mitchell, G.F., Vasan, R.S., Keaney, J.F., Lehman, B.T., Fan, S., Osypiuk, E., and Vita, J.A. (2004). Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109, 613-619.
6. Bersell, K., Arab, S., Haring, B., and Kuhn, B. (2009). Neuregulinl/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257-270.
7. Bitar, F., Lerman, A., Akhter, M.W., Hatamizadeh, P., Janmohamed, M., Khan, S., and Elkayam, U. (2006). Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathy. J Cardiovasc Pharmacol Ther 11, 197-202.
8. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
9. Brutsaert, D.L. (2003). Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83, 59-115.
10. Brutsaert, D.L., Fransen, P., Andries, L.J., De Keulenaer, G.W., and Sys, S.U. (1998). Cardiac endothelium and myocardial function. Cardiovasc Res 38, 281-290.
11. Calles-Escandon, J., and Cipolla, M. (2001). Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22, 36-52.
12. Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., Vallance, P., Vita, J., Vogel, R., and Force, I.B.R.T. (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39, 257-265.
13. Cox, D.A., Vita, J.A., Treasure, C.B., Fish, R.D., Alexander, R.W., Ganz, P., and Selwyn, A.P. (1989). Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 80, 458-465.
14. Crone, S.A., Zhao, Y.Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K.L., Chen, J., Kahn, R., Condorelli, G., Ross, J., Jr., Chien, K.R., and Lee, K.F. (2002). ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8, 459-465.
15. De Berrazueta, J.R., Guerra-Ruiz, A., Garcia-Unzueta, M.T., Toca, G.M., Laso, R.S., De Adana, M.S., Martin, M.A., Cobo, M., and Llorca, J. (2010). Endothelial dysfunction, measured by reactive hyperaemia using straingauge plethysmography, is an independent predictor of adverse outcome in heart failure. EurJ Heart Fail 12, 477-483.
16. Du, X.L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C, and Brownlee, M. (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108, 1341-1348.
17. Du, X.L., Edelstein, D., Rossetti, L., Fantus, I.G., Goldberg, H., Ziyadeh, F., Wu, J., and Brownlee, M. (2000). Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Spl glycosylation. Proc NatlAcadSci U SA97, 12222-12226.
18. Falls, D.L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284, 14-30.
19. Fischer, D., Rossa, Sv Landmesser, U., Spiekermann, Sv Engberding, Nv Hornig, B., and Drexler, H. (2005). Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26, 65-69.
20. Fujisaki, H., Ito, H., Hirata, Y., Tanaka, M., Hata, M., Lin, M., Adachi, S., Akimoto, H., Marumo, F., and Hiroe, M. (1995). Natriuretic peptides inhibit angiotensin ll-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 96, 1059-1065.
21. Galizia, M.S., Barker, A., Liao, Y., Collins, J., Carr, J., Mcdermott, M.M., and Markl, M. (2014). Wall morphology, blood flow and wall shear stress: MR findings in patients with peripheral artery disease. Eur Radiol 24, 850-856.
22. Giles, T.D., Sander, G.E., Nossaman, B.D., and Kadowitz, P.J. (2012). Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins. J Clin Hypertens (Greenwich) 14, 198-205.
23. Go, L.O., Moschella, M.C., Watras, J., Handa, K.K., Fyfe, B.S., and Marks, A.R. (1995). Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95, 888-894.
24. Godecke, A., Heinicke, T., Kamkin, A., Kiseleva, I., Strasser, R.H., Decking, U.K., Stumpe, T., Isenberg, G., and Schrader, J. (2001). Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532, 195-204.
25. Gogg, S., Smith, U., and Jansson, P.A. (2009). Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes 58, 2238-2245.
26. Gui, C, Zhu, L, Hu, M., Lei, L., and Long, Q. (2012). Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovasc Pathol 21, 414-420.
27. Gutierrez, E., Flammer, A.J., Lerman, L.O., Elizaga, J., Lerman, A., and Fernandez-Aviles, F. (2013). Endothelial dysfunction over the course of coronary artery disease. Eur Heart J 34, 3175-3181.
28. Harrison, D.G. (1997). Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100, 2153- 2157.
29. Isaka, M., Kudo, A., Imamura, M., Kawakami, H., and Yasuda, K. (2007). Endothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmias. Basic Res Cardiol 102, 154-162.
30. Jansson, P.A. (2007). Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 262, 173-183.
31. Jones, S.P., and Bolli, R. (2006). The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40, 16-23.
32. Jones, S.P., Gibson, M.F., Rimmer, D.M., Gibson, T.M., Sharp, B.R., and Lefer, D.J. (2002). Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor. J Am Coll Cardiol 40, 1172- 1178.
33. Jones, S.P., Girod, W.G., Palazzo, A.J., Granger, D.N., Grisham, M.B., Jourd'heuil, D., Huang, P.L, and Lefer, D.J. (1999). Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276, H1567-1573.
34. Jones, S.P., Greer, J.J.M., Kakkar, A.K., Ware, P.D., Turnage, R.H., Hicks, M., Van Haperen, R., De Crom, R., Kawashima, S., Yokoyama, M., and Lefer, D.J. (2004). Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 286, H276-282.
35. Jones, S.P., Greer, J.J.M., Van Haperen, R., Duncker, D.J., De Crom, R., and Lefer, D.J. (2003a). Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 100, 4891-4896.
36. Jones, S.P., Teshima, Y., Akao, M., and Marban, E. (2003b). Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ Res 93, 697-699.
37. Katz, S.D., Biasucci, L., Sabba, C, Strom, J.A., Jondeau, G., Galvao, M., Solomon, S., Nikolic, S.D., Forman, R., and Lejemtel, T.H. (1992). Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19, 918-925.
38. Kedzierski, R.M., and Yanagisawa, M. (2001). Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41, 851-876.
39. Kim, T.N., Kim, S., Yang, S.J., Yoo, H.J., Seo, J.A., Kim, S.G., Kim, N.H., Baik, S.H., Choi, D.S., and Choi, K.M. (2010). Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18Ffluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging 3, 142-148.
40. Koh, K.K., Oh, P.C., and Quon, M.J. (2009). Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res 81, 649-659.
41. Kubo, S.H., Rector, T.S., Bank, A.J., Williams, R.E., and Heifetz, S.M. (1991). Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84, 1589-1596.
42. Lejemtel, T.H., Maskin, C.S., Lucido, D., and Chadwick, B.J. (1986). Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74, 245-251.
43. Lemmens, K., Segers, V.F., Demolder, M., and De Keulenaer, G.W. (2006). Role of neuregulin-l/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 281, 19469-19477.
44. Lerman, A., and Zeiher, A.M. (2005). Endothelial function: cardiac events. Circulation 111, 363-368.
45. Li, J., Brown, L.F., Hibberd, M.G., Grossman, J.D., Morgan, J.P., and Simons, M. (1996). VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270, H1803-1811.
46. Libby, P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365-372.
47. Libby, P., Ridker, P.M., and Maseri, A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135-1143.
48. Liu, F.F., Stone, J.R., Schuldt, A.J., Okoshi, K., Okoshi, M.P., Nakayama, M., Ho, K.K., Manning, W.J., Marchionni, M.A., Lorell, B.H., Morgan, J.P., and Yan, X. (2005). Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 289, H660-666.
49. Liu, P.-Y., Liu, Y.-W., Lin, L.-J., Chen, J.-H., and Liao, J.K. (2009). Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 119, 131-138.
50. Maccarthy, P.A., and Shah, A.M. (2000). Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101, 1854-1860.
51. Majumdar, P., Chen, S., George, B., Sen, S., Karmazyn, M., and Chakrabarti, S. (2009). Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart disease. Diabetes Metab Res Rev 25, 452-463.
52. Malek, A.M., Alper, S.L., and Izumo, S. (1999). Hemodynamic shear stress and its role in atherosclerosis. JAMA 282, 2035-2042.
53. Mather, K.J., Lteif, A., Steinberg, H.O., and Baron, A.D. (2004). Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53, 2060-2066.
54. Matsumoto, T., Yoshiyama, S., Kobayashi, T., and Kamata, K. (2004). Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery. Peptides 25, 1985-1994.
55. Mccall, D.O., Mcgartland, C.P., Mckinley, M.C., Patterson, C.C., Sharpe, P., Mccance, D.R., Young, I.S., and Woodside, J.V. (2009). Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 119, 2153-2160.
56. Mcgorisk, G.M., and Treasure, C.B. (1996). Endothelial dysfunction in coronary heart disease. Curr Opin Cardiol 11, 341-350.
57. Murry, C.E., Jennings, R.B., and Reimer, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
58. Nagayama, T., Kuwakubo, F., Matsumoto, T., Fukushima, Y., Yoshida, M., Suzuki-Kusaba, M., Hisa, H., Matsumura, Y., Kimura, T., and Satoh, S. (2000). Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland. EurJ Pharmacol 406, 69-74.
59. Neglia, D., Parodi, O., Gallopin, M., Sambuceti, G., Giorgetti, A., Pratali, L., Salvadori, P., Michelassi, C, Lunardi, M., Pelosi, G., and et al. (1995). Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 92, 796-804.
60. Nohria, A., Kinlay, S., Buck, J.S., Redline, W., Copeland-Halperin, R., Kim, S., and Beckman, J.A. (2014). The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc 3, e000609.
61. Obel, N., Thomsen, H.F., Kronborg, G., Larsen, C.S., Hildebrandt, P.R., S0rensen, H.T., and Gerstoft, J. (2007). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 44, 1625-1631.
62. Paolocci, N., Biondi, R., Bettini, M., Lee, C.I., Berlowitz, CO., Rossi, R., Xia, Y., Ambrosio, G., L'abbate, A., Kass, D.A., and Zweier, J.L (2001). Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart. J Mol Cell Cardiol 33, 671-679.
63. Paulus, W.J., Vantrimpont, P.J., and Shah, A.M. (1994). Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89, 2070-2078.
64. Pierce, G.L., Lesniewski, L.A., Lawson, B.R., Beske, S.D., and Seals, D.R. (2009). Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 119, 1284-1292.
65. Potenza, M.A., Marasciulo, F.L, Chieppa, D.M., Brigiani, G.S., Formoso, G., Quon, M.J., and Montagnani, M. (2005). Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Ore Physiol 289, H813- 822.
66. Proven, A., Roderick, H.L, Conway, S.J., Berridge, M.J., Horton, J.K., Capper, S.J., and Bootman, M.D. (2006). Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J Cell Sci 119, 3363-3375.
67. Rich, S., and Mclaughlin, V.V. (2003). Endothelin receptor blockers in cardiovascular disease. Circulation 108, 2184-2190.
68. Roberts, A.C., and Porter, K.E. (2013). Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vase Dis Res 10, 472-482.
69. Ross, J. (1998). Adrenergic regulation of the force-frequency effect. Basic Res Cardiol 93 Suppl 1, 95-101.
70. Salloum, F., Yin, C, Xi, L, and Kukreja, R.C. (2003). Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Ore Res 92, 595-597.
71. Sellke, F.W., Wang, S.Y., Stamler, A., Lopez, J.J., Li, J., Li, J., and Simons, M. (1996). Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 271, H713-720.
72. Shantsila, E., Wrigley, B.J., Blann, A.D., Gill, P.S., and Lip, G.Y. (2012). A contemporary view on endothelial function in heart failure. EurJ Heart Fail 14, 873-881.
73. Shechter, M., Matetzky, S., Arad, M., Feinberg, M.S., and Freimark, D. (2009). Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. EurJ Heart Fail 11, 588- 593.
74. Shen, X., Tan, Z., Zhong, X., Tian, Y., Wang, X., Yu, B., Ramirez-Correa, G., Murphy, A., Gabrielson, K., Paolocci, N., and Gao, W.D. (2013). Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium. J Appl Physiol (1985) 115, 383-393.
75. Simionescu, M. (2007). Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vase Biol 27, 266-274.
76. Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., and Norton, L. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N EnglJ Med 344, 783-792.
77. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D., Vega, J.D., Taylor, W.R., and Griendling, K.K. (2002). Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435.
78. Suzuki, T., Kumazaki, T., and Mitsui, Y. (1993). Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191, 823-830.
79. Takahashi, K., Ghatei, M.A., Lam, H.C., O'halloran, D.J., and Bloom, S.R. (1990). Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33, 306-310.
80. Targonski, P.V., Bonetti, P.O., Pumper, G.M., Higano, ST., Holmes, D.R., Jr., and Lerman, A. (2003). Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 107, 2805-2809.
81. Tirziu, D., Giordano, F.J., and Simons, M. (2010). Cell communications in the heart. Circulation 122, 928-937.
82. Treasure, C.B., Vita, J.A., Cox, D.A., Fish, R.D., Gordon, J.B., Mudge, G.H., Colucci, W.S., Sutton, M.G., Selwyn, A.P., Alexander, R.W., and et al. (1990). Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81, 772-779.
83. Triant, V.A., Lee, H., Hadigan, C, and Grinspoon, S.K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 92, 2506-2512.
84. Vasquez-Vivar, J., Martasek, P., Whitsett, J., Joseph, J., and Kalyanaraman, B. (2002). The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 362, 733-739.
85. Versari, D., Daghini, E., Virdis, A., Ghiadoni, L, and Taddei, S. (2009). Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 32 Suppl 2, S314-321.
86. Vita, J.A., and Keaney, J.F., Jr. (2002). Endothelial function: a barometer for cardiovascular risk? Circulation 106, 640-642.
87. Vita, J.A., Treasure, C.B., Nabel, E.G., Mclenachan, J.M., Fish, R.D., Yeung, A.C., Vekshtein, V.I., Selwyn, A.P., and Ganz, P. (1990). Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81, 491-497.
88. Werner, C, Fiirster, T., Widmann, T., Poss, J., Roggia, C, Hanhoun, M., Scharhag, J., Biichner, N., Meyer, T., Kindermann, W., Haendeler, J., Bohm, M., and Laufs, U. (2009). Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 120, 2438-2447.
89. Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D.W., Adiarto, S., Iwasa, N., Yagi, K., Miyagawa, K., Rikitake, Y., Suzuki, T., Kisanuki, Y.Y., Yanagisawa, M., and Hirata, K. (2010). Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121, 2407-2418.
90. Yamamoto, S., Matsumoto, N., Kanazawa, M., Fujita, M., Takaoka, M., Gariepy, C.E., Yanagisawa, M., and Matsumura, Y. (2005). Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Circulation 111, 302-309.
91. Yorikane, R., Sakai, S., Miyauchi, T., Sakurai, T., Sugishita, Y., and Goto, K. (1993). Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett 332, 31-34.
92. Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., and Bohm, M. (2002). Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Cardiovasc Res 53, 363-371.